A long-acting HIV drug arrives in Zimbabwe for some at highest risk

Zimbabwe roll-out of long-acting HIV prevention drug gets underway

With clinical studies demonstrating near-total protection, lenacapavir has been described by some health officials as a turning point for high-risk groups.

Zimbabwe is one of the first to roll out new and long-acting HIV drug

HARARE, Zimbabwe — Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe’s capital, Harare. They...

A long-acting HIV drug arrives in Zimbabwe for some at highest risk

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year.

Zimbabwe rolls out new long-acting HIV prevention drug

Zimbabwe has begun administering a groundbreaking long-acting injectable drug designed to prevent HIV infection, marking a significant step forward in the country’s ongoing fight against the epidemic.

Epworth welcomes new HIV prevention drug

Source: Epworth welcomes new HIV prevention drug – The Standard In a landmark moment for Zimbabwe’s HIV response, the government officially launched lenacapavir (LEN)  in Epworth, a high-density suburb on the outskirts of Harare — deliberately taking the breakthrough prevention drug to a community that embodies both vulnerability and resilience. The six-month injectable HIV prevention drug was launched on Thursday by Health and Child Care minist…